Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics, safety and immunogenicity of single doses of belatacept administered subcutaneously to healthy subjects

Next Previous
Trial Profile

Pharmacokinetics, safety and immunogenicity of single doses of belatacept administered subcutaneously to healthy subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 29 Sep 2008 Planned number of patients changed from 154 to actual number 47 as reported by ClinicalTrials.gov.
  • 10 Sep 2008 Actual start date changed from Jun 2008 to Aug 2008 as reported by Clinicaltrials.gov.
  • 10 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top